Arthritis during interferon beta-1b treatment in multiple sclerosis.

Abstract

Interferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy. In this case report, we present clinical and laboratory… (More)

Topics

Cite this paper

@article{Altinta2002ArthritisDI, title={Arthritis during interferon beta-1b treatment in multiple sclerosis.}, author={Aytekin Altintaş and Yesne Alici and Meltem Alkan Melikoğlu and Aksel Siva}, journal={Multiple sclerosis}, year={2002}, volume={8 6}, pages={534-6} }